These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1553366)

  • 1. A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer.
    Abbruzzese JL; Gholson CF; Daugherty K; Larson E; DuBrow R; Berlin R; Levin B
    Pancreas; 1992; 7(2):165-71. PubMed ID: 1553366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
    J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo modulation of cisplatin cytotoxicity by the cholecystokinin antagonist MK-329 in human pancreatic cancer xenografts.
    Jamshidipour R; Pinho EB; Howell SB
    Anticancer Res; 1994; 14(6B):2611-6. PubMed ID: 7872689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell line.
    Jamshidipour R; Pinho EB; Hom DK; Howell SB
    Cancer Chemother Pharmacol; 1994; 34(6):484-90. PubMed ID: 7923559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK antagonist MK-329.
    O'Neill MF; Dourish CT; Iversen SD
    Neuropharmacology; 1989 Mar; 28(3):243-7. PubMed ID: 2725851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cholecystokinin-stimulated pancreaticobiliary output in man by the cholecystokinin receptor antagonist MK-329.
    Cantor P; Olsen O; Gertz BJ; Gjorup I; Worning H
    Scand J Gastroenterol; 1991 Jun; 26(6):627-37. PubMed ID: 1713709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9- to 12-day-old rat pups.
    Smith GP; Tyrka A; Gibbs J
    Pharmacol Biochem Behav; 1991 Jan; 38(1):207-10. PubMed ID: 2017446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postponement of satiety by blockade of brain cholecystokinin (CCK-B) receptors.
    Dourish CT; Rycroft W; Iversen SD
    Science; 1989 Sep; 245(4925):1509-11. PubMed ID: 2781294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asperlicin: a unique nonpeptide cholecystokinin antagonist.
    Zucker KA; Adrian TE; Zdon MJ; Ballantyne GH; Modlin IM
    Surgery; 1987 Aug; 102(2):163-70. PubMed ID: 2441481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the CCK receptor antagonist MK-329 on food intake in pigs.
    Ebenezer IS; de la Riva C; Baldwin BA
    Physiol Behav; 1990 Jan; 47(1):145-8. PubMed ID: 2326329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.
    Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Coker LD; Turnbull TA; Morita ET
    J Clin Invest; 1989 Oct; 84(4):1220-5. PubMed ID: 2794058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
    Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT
    Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of peripheral cholecystokinin receptors in vivo using the cholecystokinin antagonist [3H](+/-)-MK-329.
    Sadzot B; Sheldon J; Dannals RF; Ravert HT; Wagner HN; Frost JJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):195-201. PubMed ID: 2253694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastrin-releasing peptide and cholecystokinin in the regulation of exocrine pancreatic secretion in dogs.
    Nustede R; Schmidt WE; Lohmann C; Köhler H; Schlemminger R; Schafmayer A
    Digestion; 1993; 54(2):79-83. PubMed ID: 8319843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist.
    Wolkowitz OM; Gertz B; Weingartner H; Beccaria L; Thompson K; Liddle RA
    Biol Psychiatry; 1990 Jul; 28(2):169-73. PubMed ID: 2378921
    [No Abstract]   [Full Text] [Related]  

  • 16. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Satiety induced by endogenous and exogenous cholecystokinin is mediated by CCK-A receptors in mice.
    Weatherford SC; Chiruzzo FY; Laughton WB
    Am J Physiol; 1992 Apr; 262(4 Pt 2):R574-8. PubMed ID: 1566921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent effects of CCK and devazepide in male and female rats.
    Salorio CF; Hammond PB; Schwartz GJ; McHugh PR; Moran TH
    Physiol Behav; 1994 Oct; 56(4):645-8. PubMed ID: 7800726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility.
    Bock MG; DiPardo RM; Rittle KE; Evans BE; Freidinger RM; Veber DF; Chang RS; Chen TB; Keegan ME; Lotti VJ
    J Med Chem; 1986 Oct; 29(10):1941-5. PubMed ID: 3761313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.